Latin America Vascular Closure Devices Market to hit USD 111.3 Mn by 2021

The Latin America Vascular Closure Devices Market was worth USD 78.9 Million in 2016 and is estimated to be growing at a CAGR of 7%, to reach USD 111.3 Million by 2021. A vast number of diagnostic and therapeutic procedures regarding cardiovascular system are conducted using femoral artery as the access point. Manual compression was commonly used to close femoral artery after the procedure. It became a sophisticated procedure with the use of anticoagulants and waiting time for blood clotting.

Browse Market data tables and in-depth TOC of the Latin America Vascular Closure Devices Market to 2021 @ http://www.marketdataforecast.com/market-reports/latin-america-vascular-closure-devices-market-3540/

Vascular closure devices were introduced as an alternate for this problem. For valve replacement procedures which require a large incision on femoral artery, VCDs are the best option as they do not require surgical assistance afterwards. It reduces the discharge time and can be shifted into ambulance if required.

The demand for vascular closure devices is increasing due to the increase in awareness and comfort levels for physicians as well as patients. Developments made to the existing devices, technological advancements and increase in cardiovascular diseases are expected to drive the market. However, increasing access point complications and risks associated with the use of VCDs are restraining the market growth.

Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/latin-america-vascular-closure-devices-market-3540/request-sample

The Latin America vascular closure devices market is categorized based on the type, access, procedure, end user and by region. Based on the type of devices, the market is categorized into passive approximators, Active Approximators and External Hemostatic Devices. Active approximators segment is projected to hold the largest share in the VCDs market due to their high efficiency. Passive approximators are again categorized into Sealant or Gel based devices, Collagen plugs and Compression assist devices. Active approximators are again categorized into Suture based devices and clip based devices. Based on access to the artery, the market is categorized into Femoral and radial access. Femoral access the largest market share because it is largely adopted by physicians around the globe. Based on procedure involved, the market is categorized into interventional cardiology and interventional radiology or vascular surgery. Based on end user, the market is categorized into acute care facilities, hospitals and clinics. Acute care facilities are the largest market segment due to the increase of emergency cases in cardiovascular diseases.

On the basis of region, the Latin America VCDs market is segmented into Brazil, Argentina, Mexico and rest of South America. The vascular closure devices market is rapidly growing due to the investment of emerging economies like Brazil and Mexico in healthcare development and large population base providing huge opportunities.

Avail discount @ http://www.marketdataforecast.com/market-reports/latin-america-vascular-closure-devices-market-3540/request-discount

Cardinal Health, W L. Gore & Associates, Merit Medical Systems, Inc., Biotronik GMBH & CO.KG, Abbott Vascular, Medtronic, Boston Scientific Corporation, Cardival Medical, Inc., Essential Medical, Inc., St. Jude Medical, TZ Medical, Inc. and Scion BioMedical are some of the major players in Latin America VCDs market.

About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail:abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

Comments

Post a Comment

Popular posts from this blog

Rice Protein Market value worth USD 85.3 million 2021 | Market Data Forecast

Image
The Global Rice Protein Market was worth USD 63.3 million in 2016, and is expected to grow at a CAGR of 6.15%, to reach USD 85.3 million by 2021. Rice protein is considered as an alternative to the popular whey and soy proteins. It is extracted by treating sprouted rice with enzymes to separate carbohydrates from proteins. The extracted protein is added directly or as flavored in the industries. Rice protein flavor is preferred to whey protein in artificial flavoring industry due to its distinct taste and flavor and it is also less unpleasant than whey protein. Rice protein contains high quantities of cysteine and sulphur containing amino acids. It is generally used in conjunction with pea protein to balance the lack of lysine in rice protein. The amino acids present in rice protein are essential in tissue rebuilding and it is also found to aid in the recovery of muscles. Browse market data tables and in-depth TOC of the Rice Protein Market to 2021 @ https://www.marketdata...
Read more

Europe Temperature Management Market: Sales, Revenue, Gross Margin Analysis 2021 | Market Data Forecast

Image
According to the report Europe Temperature Management Market, published by Market Data Forecast, the market is projected to reach USD 810 million by 2021, at a CAGR of 2.7% from 2016 to 2021. Temperature Management are pharmaceutical drug products which are semi synthesized from biological sources. Unlike completely synthesized pharmaceuticals, they contain several biological components such as blood and its components, somatic cells, tissues and recombinant therapeutic proteins. The biological sources include animals, humans, plants and microorganisms. Proteins and nucleic acids which are genetically modified are also used to synthesize these drugs. These drugs are generally used when no other type of treatment or medicines fail to treat the disease or condition. Drugs which are synthesized using cells or tissue engineering, gene therapy and somatic cell therapy are also known as advanced therapy medicinal products by the European medicines Agency (EMA). Temperature Manag...
Read more

Global Antibodies Market Research Report | Industry Analysis and Forecast 2016-2021

Image
According to the report Global Antibodies Market , published by Market Data Forecast, The Global Market was worth $ 95.217 Billion in 2016 and estimated to reach $ 161.897 Billion by the end of 2021 with a growing potential of 11.20 %.  Antibodies are proteins that are produced in response to specific antigens by plasma cells. They are also called as immunoglobulin. These antibodies are used as diagnostics as well as Therapeutic purposes for several indications of diseases, including but not limited to, rheumatoid arthritis, non-Hodgkin lymphoma, psoriasis, Crohn’s disease, macular degeneration, hypercholesterolemia, and asthma. Owing to a number of product launches, antibodies market is projected to witness steady growth. Effective harmonisation of product development, approval and registration guidelines in some of the major markets, such as United States and European Union can speed up the research and development of antibody related products. Browse market data tab...
Read more